
GC31874
Olutasidenib
Also listed as Olutasidenib (FT-2102)
Olutasidenib (FT-2102) (FT-2102) is a highly potent, orally active, brain penetrant and selective inhibitor of mutant Isocitrate dehydrogenase 1 (IDH1), with IC50 values of 21·2 nM and 114 nM for IDH1- R132H and IDH1- R132C, respectively
ChemicalCAS1887014-12-1MW354.79FormulaC18H15ClN4O2
- CAS number
- 1887014-12-1
- Molecular weight
- 354.79
- Formula
- C18H15ClN4O2
- Solubility
- DMSO: 125 mg/mL (352·32 mM)
- InChIKey
- NEQYWYXGTJDAKR-JTQLQIEISA-N
- Catalogue number
- GC31874
- Brand
- GLPBIO
Computed properties PubChem CID 118955396 · XLogP 2.5 · TPSA 85.2 Ų · H-bond donors 2
- XLogP
- 2.5
- TPSA
- 85.2 Ų
- H-bond donors
- 2
- H-bond acceptors
- 4
- Rotatable bonds
- 3
- Heavy atoms
- 25
SMILES C[C@@H](C1=CC2=C(C=CC(=C2)Cl)NC1=O)NC3=CC=C(N(C3=O)C)C#N
Computed descriptors from PubChem (CID 118955396), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il